Welcome to My Site.

Thanks for taking time to visit my site. For more information, please check out my home page: http://adamkhoowealth.com/

Sunday, September 28, 2014

Roche Breast Cancer Drug Appears to Greatly Extend Patients’ Lives by ANDREW POLLACK



By ANDREW POLLACK


Perjeta, approved by the F.D.A. in 2012, prolonged median survival time about 16 months in a trial of 808 people with metastatic breast cancer.


Published: September 29, 2014 at 4:00AM


from NYT Business Day http://ift.tt/1mCJi8r

via IFTTT








from WordPress http://ift.tt/Yu7Vcj
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)